Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.

Saved in:
Bibliographic Details
Title: Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis. Results of two randomized treatment trials of six weeks duration.
Authors: Myllykangas-Luosujärvi R; Kuopio University Hospital, Kuopio, Finland., Lu HS, Chen SL, Choon D, Amante C, Chow CT, Pasero G, Genti G, Sarembock B, Zerbini CA, Vrijens F, Moan A, Rodgers DB, De Tora L, Laurenzi M
Corporate Authors: Naproxen 901 OF study group Naproxen 901 OC study group
Source: Scandinavian journal of rheumatology [Scand J Rheumatol] 2002; Vol. 31 (6), pp. 337-44.
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 0321213 Publication Model: Print Cited Medium: Print ISSN: 0300-9742 (Print) Linking ISSN: 03009742 NLM ISO Abbreviation: Scand J Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0300-9742
DOI:10.1080/030097402320817059